DMAQ | Deep Medicine Acquisition Corp. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	2.9600 - 7.69
52 Week Range	2.9600 - 19.91
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	73,881
Average Volume	14,214
Shares Outstanding	4,357,960
Market Cap	12,899,562
Sector	Financial Services
Industry	Shell Companies
IPO Date	2021-12-02

Valuation
Profitability
Growth
Health
P/E Ratio	-22.77
Forward P/E Ratio	N/A
EPS	-0.13
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	2
Country	USA

Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.

DMAQ's peers: BRKH, PFTA

*Chart delayed

Analyzing fundamentals for DMAQ we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see DMAQ Fundamentals page.

Watching at DMAQ technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on DMAQ Technicals page.